
    
      The rationale to study the downregulation of topoisomerase enzyme in ovarian cancer in
      relationship to the cell cycle distribution of the cancer cells after a prolonged continuous
      exposure to topo I and II poisons is to better understand the relationship between cell cycle
      and topo poisoning, which may lead to better clinical trial designs.
    
  